RBV Capital: A Swiss-based life sciences venture fund investing in diverse global healthcare solutions.
Location
Zug, CH
Founded
2013
RBV Capital is a dedicated life sciences venture fund based in Zug, Switzerland, focusing on pharmaceuticals, biologics, digital healthcare products, and medical devices that address unmet medical and market needs with global potential. The firm typically invests in Series B and Series C rounds, supporting companies with significant growth and development prospects.
Notable portfolio companies include Immusoft and Pipeline Therapeutics, which have raised $20 million and $112 million, respectively. RBV Capital's investment philosophy centers on fostering innovative biomedical projects. The firm offers unique value-add services, leveraging its extensive industry expertise to support portfolio companies in achieving global outreach and impact.
RBV Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages